Stayble Therapeutics AB
Research Stayble Therapeutics AB (STABL) on Bullrun: market cap SEK 13.19M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSTABL
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 13.19M
- Financial periodQ4 2025
- Net income-SEK 1.53M
- Free cash flow-SEK 1.34M
Valuation Snapshot
latest market cap is SEK 13.19M.
About Stayble Therapeutics AB
Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.
Frequently asked questions
What is Stayble Therapeutics AB's market cap?
Stayble Therapeutics AB's market capitalization is SEK 13.19M.
What does Stayble Therapeutics AB do?
Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.